David J. Loury,Joseph J. Buggy,Tarak D. Mody,Erik J. Verner,Norbert Purro,Sriram Balasubramanian,Ioana Kloos,Stephane Depil
申请号：
US14344314
公开号：
US20140341989A1
申请日:
2011.09.13
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include bendamustine, or a pharmaceutically acceptable salt thereof and an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described.
